The COVID-GRAM Tool for Patients Hospitalized With COVID-19 in Europe
- PMID: 33818609
- PMCID: PMC8022262
- DOI: 10.1001/jamainternmed.2021.0491
The COVID-GRAM Tool for Patients Hospitalized With COVID-19 in Europe
Abstract
This study applies a clinical risk assessment tool (COVID-GRAM) developed in China to a population of patients hospitalized with COVID-19 in Spain to evaluate the tool’s usefulness in Europe.
Conflict of interest statement
Comment on
-
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033. JAMA Intern Med. 2020. PMID: 32396163 Free PMC article.
References
-
- Liang W, Liang H, Ou L, et al. ; China Medical Treatment Expert Group for COVID-19 . Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081-1089. doi:10.1001/jamainternmed.2020.2033 - DOI - PMC - PubMed
-
- Steinberg E, Balakrishna A, Habboushe J, Shawl A, Lee J. Calculated decisions: COVID-19 calculators during extreme resource-limited situations. Emerg Med Pract. 2020;22(4)(suppl):CD1-CD5. - PubMed
-
- Metlay JP, Waterer GW, Long AC, et al. . Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581ST - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical